A clinical formulation indicated for Erectile Dysfunction. Treatment promotes increased blood flow to the pelvic region, which supports the achievement and maintenance of a firm physical response during intimacy.
A potent PDE5 inhibitor utilized to manage erectile dysfunction and designed to support blood flow for achieving a sustainable erection during sexual stimulation.
Mechanism of Action
It inhibits the PDE5 enzyme, increasing levels of cyclic GMP. This allows for smooth muscle relaxation and increased blood inflow to the penis.
Route of Administration
Oral
Onset Time
25–60 minutes
Duration
4–5 hours
Contraindications
Concurrent use of nitrates, Severe heart disease, Recent heart attack, Allergy to vardenafil
Information for Vilitra is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
